2025-10-17 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc. (HIMS) based on the data you provided.

## Hims & Hers Health Inc. (HIMS) Analysis

**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions directly to consumers.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 254.22%
*   **VOO Cumulative Return:** 70.38%
*   **Absolute Difference:** 183.84%
*   **Relative Difference:** 67.4%

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) over the period examined. However, the "relative difference" of 67.4% indicates that while HIMS is currently outperforming, it is positioned in the upper range of its historical performance relative to the S&P 500. This suggests that while the outperformance is strong, it's not unprecedented, and there have been periods where the gap was narrower.
The relative difference of 67.4% (based on min/max range of -86.1 to 321.5) means HIMS's current outperformance is closer to its historical average relative to the S&P 500, considering its past volatility.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B) |
|------------|----------|----------|----------|--------|--------|
| 2019-2021  | -42.0%   | 74.4%    | -81.0%   | 0.0    | 1.6    |
| 2020-2022  | -19.0%   | 78.6%    | -18.0%   | -0.0   | 1.6    |
| 2021-2023  | -65.0%   | 78.6%    | -67.0%   | -0.1   | 2.2    |
| 2022-2024  | 119.0%   | 79.4%    | 98.0%    | -0.0   | 6.0    |
| 2023-2025  | 259.0%   | 80.8%    | 198.0%   | 0.1    | 13.4   |

**Analysis:**

*   **CAGR:**  The CAGR (Compound Annual Growth Rate) shows a significant turnaround from negative values in earlier periods to a very strong positive growth in the most recent period (2023-2025). This indicates a strong growth trajectory recently.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant price volatility and risk.
*   **Alpha:**  Alpha has dramatically improved, showing a substantial ability to generate returns above the benchmark, especially in the latest period.
*   **Beta:** Beta values are close to zero or slightly negative in earlier periods, implying that HIMS was less sensitive to market movements (or moved inversely). However, the Beta has slightly increased to 0.1 recently, which implies HIMS's price is now slightly more correlated to the market.
*   **Cap(B):** Market Cap has increased significantly, which confirms the company has grown over time.

### 2. Recent Price Action

*   **Current Price:** 54.02
*   **Last Market Data:** Price: 59.15, Previous Close: 62.76, Change: -5.75
*   **5-Day Moving Average:** 55.20
*   **20-Day Moving Average:** 55.58
*   **60-Day Moving Average:** 52.36

**Analysis:**

*   The stock price (54.02) is below all three moving averages (5, 20, and 60-day), suggesting a short-term downtrend.
*   The last market data shows a significant price drop (Change: -5.75), indicating negative momentum. The drop from the previous close of 62.76 to 59.15 suggests a sudden negative catalyst or market sentiment shift.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 51.51 (Neutral)
*   **PPO:** -0.8781 (Slightly Oversold)
*   **Hybrid Signal:** Cash 0%, Buy 100% (Very Safe - MRI:0.90)
*   **Delta_Previous_Relative_Divergence:** -4.5 (Negative - Short-Term Decline)
*   **Expected Return:** 2.5% (Long-Term Outperformance vs. S&P 500)

**Analysis:**

*   The MRI of 0.8 suggests a "Medium Investment Recommended," indicating a moderate level of risk.
*   RSI at 51.51 is neutral, indicating neither overbought nor oversold conditions.
*   The PPO is slightly negative, suggesting a potential oversold condition and a possible buy signal.
*   The "Hybrid Signal" recommends a 100% buy with a very safe rating, likely due to the high MRI value used in that particular model (0.90).
*   The negative "Delta_Previous_Relative_Divergence" confirms the short-term downward trend.
*   The expected return of 2.5% implies that, over the long term, the stock is expected to outperform the S&P 500 by this margin if a dollar-cost averaging strategy is used.
*   The price drop in the last market data (-5.75) confirms some recent downside momentum, potentially linked to recent news or market sentiment.

### 4. Recent News & Significant Events

*   **Positive Headlines:** Several headlines highlight positive developments, including increased accessibility to technology-driven healthcare, the company being on track to book $1 billion in revenues from the women's segment, and potential buying opportunities.
*   **Analyst Report:**  The presence of a Morningstar analyst report suggests ongoing coverage and attention from institutional investors.
*   **Specific Headlines:**
    *   **"Hims & Hers Elevates Technology-Driven Healthcare Accessibility":** This suggests positive developments in the company's service offerings and potential market expansion.
    *   **"Hims & Hers (HIMS) Soars 16% as Firm On Track to Book $1 Billion Revenues from Women Segment":** This indicates strong financial performance and growth potential in a specific market segment.
    *   **"How To Buy HIMS For A 24% Discount, Or Achieve an 82% Annual Return":** This suggests potential short-term buying opportunities and significant long-term upside potential.
    *   **"Why Hims & Hers Stock Blasted 16% Higher on Wednesday":** This confirms a recent positive market reaction, potentially due to the news mentioned above.

### 4-2. Analyst Opinions

*   **Consensus:** Hold (2.92)
*   **Target Price:** Average: $47.42, High: $85.00, Low: $25.00

**Analysis:**

*   The analyst consensus of "Hold" suggests a neutral outlook on the stock.
*   The wide range in target prices indicates uncertainty among analysts regarding the future performance of the stock. The current price (54.02) is above the average target price ($47.42), suggesting that analysts, on average, believe the stock is currently overvalued or has limited upside. However, some analysts have much higher price targets ($85.00), indicating significant potential if the company performs exceptionally well.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-08-04 | 0.19 | 0.54 B$    |
| 2025-05-05 | 0.22 | 0.59 B$    |
| 2024-11-04 | 0.35 | 0.40 B$    |
| 2024-08-05 | 0.06 | 0.32 B$    |
| 2025-08-04 | 0.06 | 0.32 B$    |

**Analysis:**

* The EPS and Revenue have increased over time, indicating positive growth.
* However, there may be duplicate data since 2025-08-04 row is repeated.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.54B  | 76.39%        |
| 2025-03-31 | $0.59B  | 73.50%        |
| 2024-12-31 | $0.48B  | 76.81%        |
| 2024-09-30 | $0.40B  | 79.16%        |
| 2024-06-30 | $0.32B  | 81.30%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-06-30 | $0.56B  | 7.55%   |
| 2025-03-31 | $0.55B  | 9.01%   |
| 2024-12-31 | $0.48B  | 5.46%   |
| 2024-09-30 | $0.44B  | 17.18%  |
| 2024-06-30 | $0.36B  | 3.67%   |

**Analysis:**

*   **Revenue:** Revenue shows a clear upward trend, indicating strong business growth.
*   **Profit Margin:** The profit margin is consistently high, reflecting efficient operations and pricing strategies. However, the margin has decreased slightly in recent quarters.
*   **Equity:** Equity is also trending upward, indicating a strengthening financial position.
*   **ROE:** Return on Equity (ROE) is fluctuating, with a recent decrease. This could be due to various factors, including increased investment in growth initiatives.

### 7. Overall Assessment

Hims & Hers Health Inc. (HIMS) presents a mixed picture.

**Strengths:**

*   **High Growth:** Strong revenue growth and positive EPS trends.
*   **Outperformance:** Significant historical outperformance compared to the S&P 500.
*   **Positive News:** Recent positive news headlines regarding revenue growth and market expansion.
*   **High Profit Margins:** Consistently high profit margins.
*   **Long-Term Potential:** Positive long-term expected return and analyst coverage.

**Weaknesses:**

*   **High Volatility:** High Maximum Drawdown indicates significant price volatility.
*   **Recent Downtrend:** Recent price decline and negative short-term momentum.
*   **Neutral Analyst Consensus:** Analyst consensus is "Hold," with a wide range in price targets, indicating uncertainty.
*   **Decreasing Profit Margin and ROE:** Profit margin and ROE have decreased slightly in recent quarters.

**Investment Recommendation:**

Based on the data, a cautious approach is warranted.

*   **Short-Term:** The recent price decline and negative momentum suggest potential downside risk in the short term.
*   **Long-Term:** The company's strong growth potential, positive news, and high profit margins make it an interesting long-term investment.

**Strategy:**

*   **Dollar-Cost Averaging:** A dollar-cost averaging strategy could be a suitable approach to mitigate the risk associated with the stock's volatility.
*   **Monitor News and Earnings:** Closely monitor news and earnings releases to stay informed about the company's performance and any potential catalysts for price movements.
*   **Consider Analyst Opinions:** Take analyst opinions into account but conduct your own due diligence to form an independent investment decision.
*   **Risk Tolerance:** Consider your own risk tolerance and investment objectives before investing in HIMS. The stock's high volatility may not be suitable for all investors.

**In summary:** HIMS is a high-growth, high-volatility stock with significant long-term potential. While the recent price decline and neutral analyst consensus suggest caution in the short term, the company's strong fundamentals and positive news make it an interesting investment for those with a higher risk tolerance and a long-term investment horizon.
